Cervical cancer is the second most frequent
cancer in women worldwide and is associated with genetic alterations,
infection with human papilloma virus (HPV), angiogenesis and inflammatory processes. The idea that
inflammation is involved in
tumorigenesis is supported by the frequent appearance of
cancer in areas of chronic
inflammation. On the other hand, the inflammatory response is controlled by the action of anti-inflammatory mediators, among these mediators,
annexin A1 (ANXA1), a 37 kDa
protein was detected as a modulator of inflammatory processes and is expressed by
tumor cells. The study was carried out on the epithelial
cancer cell line (SiHa) treated with the
peptide of
annexin A1 (ANXA1Ac2-26). We combined subtraction hybridization approach, Ingenuity Systems software and quantitative PCR, in order to evaluate gene expression influenced by ANXA1. We observed that ANXA1Ac2-26 inhibited proliferation in SiHa cells after 72h. In these cells, 55 genes exhibited changes in expression levels in response to
peptide treatment. Six genes were selected and the expression results of 5 up-regulated genes (TPT1, LDHA, NCOA3, HIF1A, RAB13) and one down-regulated gene (ID1) were research by real time quantitative PCR. Four more genes (BMP4, BMPR1B, SMAD1 and SMAD4) of the ID1 pathway were investigated and only one (BMPR1B) shows the same down regulation. The data indicate the involvement of ANXA1Ac2-26 in the altered expression of genes involved in tumorigenic processes, which could potentially be applied as a therapeutic
indicator of
cervical cancer.